nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0369	0.0434	CcSEcCtD
Carboprost Tromethamine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0297	0.035	CcSEcCtD
Carboprost Tromethamine—Injection site pain—Furosemide—dilated cardiomyopathy	0.0268	0.0314	CcSEcCtD
Carboprost Tromethamine—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0264	0.031	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0225	0.0264	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0201	0.0236	CcSEcCtD
Carboprost Tromethamine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0195	0.023	CcSEcCtD
Carboprost Tromethamine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.0185	0.0218	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0169	0.0198	CcSEcCtD
Carboprost Tromethamine—Thirst—Furosemide—dilated cardiomyopathy	0.0167	0.0196	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0164	0.0193	CcSEcCtD
Carboprost Tromethamine—Lethargy—Furosemide—dilated cardiomyopathy	0.0162	0.019	CcSEcCtD
Carboprost Tromethamine—Wheezing—Lisinopril—dilated cardiomyopathy	0.0159	0.0187	CcSEcCtD
Carboprost Tromethamine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.0147	0.0172	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.0146	0.0171	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0143	0.0168	CcSEcCtD
Carboprost Tromethamine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0137	0.0162	CcSEcCtD
Carboprost Tromethamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0127	0.015	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.0123	0.0144	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0122	0.0144	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0113	0.0133	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0106	0.0124	CcSEcCtD
Carboprost Tromethamine—Asthma—Lisinopril—dilated cardiomyopathy	0.0103	0.0121	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0102	0.012	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.01	0.0118	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0098	0.0115	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00956	0.0112	CcSEcCtD
Carboprost Tromethamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00947	0.0111	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00918	0.0108	CcSEcCtD
Carboprost Tromethamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00911	0.0107	CcSEcCtD
Carboprost Tromethamine—Rash—Spironolactone—dilated cardiomyopathy	0.00903	0.0106	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00902	0.0106	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.009	0.0106	CcSEcCtD
Carboprost Tromethamine—Headache—Spironolactone—dilated cardiomyopathy	0.00898	0.0105	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00891	0.0105	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00865	0.0102	CcSEcCtD
Carboprost Tromethamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00858	0.0101	CcSEcCtD
Carboprost Tromethamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00851	0.01	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00779	0.00916	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00768	0.00902	CcSEcCtD
Carboprost Tromethamine—Shock—Furosemide—dilated cardiomyopathy	0.00767	0.00901	CcSEcCtD
Carboprost Tromethamine—Flushing—Lisinopril—dilated cardiomyopathy	0.00764	0.00898	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00754	0.00886	CcSEcCtD
Carboprost Tromethamine—Chills—Lisinopril—dilated cardiomyopathy	0.00739	0.00868	CcSEcCtD
Carboprost Tromethamine—Tension—Lisinopril—dilated cardiomyopathy	0.00703	0.00826	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.007	0.00823	CcSEcCtD
Carboprost Tromethamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00696	0.00818	CcSEcCtD
Carboprost Tromethamine—Back pain—Lisinopril—dilated cardiomyopathy	0.00693	0.00815	CcSEcCtD
Carboprost Tromethamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00693	0.00814	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00689	0.0081	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00675	0.00794	CcSEcCtD
Carboprost Tromethamine—Pain—Furosemide—dilated cardiomyopathy	0.00667	0.00783	CcSEcCtD
Carboprost Tromethamine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00655	0.00769	CcSEcCtD
Carboprost Tromethamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00644	0.00757	CcSEcCtD
Carboprost Tromethamine—Syncope—Lisinopril—dilated cardiomyopathy	0.00643	0.00755	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00642	0.0431	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00633	0.00744	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.0063	0.0074	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00629	0.0422	CbGpPWpGaD
Carboprost Tromethamine—Cough—Lisinopril—dilated cardiomyopathy	0.00625	0.00735	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00616	0.00724	CcSEcCtD
Carboprost Tromethamine—Chest pain—Lisinopril—dilated cardiomyopathy	0.0061	0.00717	CcSEcCtD
Carboprost Tromethamine—Myalgia—Lisinopril—dilated cardiomyopathy	0.0061	0.00717	CcSEcCtD
Carboprost Tromethamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00608	0.00714	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00585	0.00687	CcSEcCtD
Carboprost Tromethamine—Infection—Lisinopril—dilated cardiomyopathy	0.00581	0.00683	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00577	0.0387	CbGpPWpGaD
Carboprost Tromethamine—Shock—Lisinopril—dilated cardiomyopathy	0.00575	0.00676	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00574	0.00675	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00571	0.00671	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00565	0.00664	CcSEcCtD
Carboprost Tromethamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00559	0.00657	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00533	0.00627	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00533	0.00626	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00525	0.00617	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00521	0.00613	CcSEcCtD
Carboprost Tromethamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.0052	0.00611	CcSEcCtD
Carboprost Tromethamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00515	0.00606	CcSEcCtD
Carboprost Tromethamine—Pain—Lisinopril—dilated cardiomyopathy	0.005	0.00588	CcSEcCtD
Carboprost Tromethamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00496	0.00582	CcSEcCtD
Carboprost Tromethamine—Rash—Furosemide—dilated cardiomyopathy	0.00491	0.00578	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00491	0.00577	CcSEcCtD
Carboprost Tromethamine—Headache—Furosemide—dilated cardiomyopathy	0.00488	0.00574	CcSEcCtD
Carboprost Tromethamine—Nausea—Furosemide—dilated cardiomyopathy	0.00463	0.00544	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00462	0.00543	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00453	0.0304	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00431	0.00506	CcSEcCtD
Carboprost Tromethamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.0042	0.00493	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.004	0.0047	CcSEcCtD
Carboprost Tromethamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00387	0.00454	CcSEcCtD
Carboprost Tromethamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00372	0.00437	CcSEcCtD
Carboprost Tromethamine—Rash—Lisinopril—dilated cardiomyopathy	0.00369	0.00433	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00368	0.00433	CcSEcCtD
Carboprost Tromethamine—Headache—Lisinopril—dilated cardiomyopathy	0.00366	0.00431	CcSEcCtD
Carboprost Tromethamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00347	0.00408	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0027	0.0181	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00268	0.018	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00264	0.0177	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00263	0.0176	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00251	0.0168	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00245	0.0165	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00243	0.0163	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.0024	0.0161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00238	0.0159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00235	0.0158	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00231	0.0155	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00231	0.0155	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00226	0.0152	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00226	0.0152	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00215	0.0144	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0021	0.0141	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00208	0.014	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00207	0.0139	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00204	0.0137	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00203	0.0136	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00197	0.0132	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00193	0.0129	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00189	0.0127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00185	0.0124	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00178	0.0119	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00176	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00176	0.0118	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00174	0.0117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00172	0.0116	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00172	0.0116	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00169	0.0113	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00169	0.0113	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00165	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00165	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00164	0.011	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0016	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00158	0.0106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00155	0.0104	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00135	0.00908	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00132	0.00889	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00128	0.00861	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00126	0.00843	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00125	0.00839	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00122	0.00821	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00117	0.00786	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00115	0.0077	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000995	0.00667	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000995	0.00667	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000974	0.00653	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000974	0.00653	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000952	0.00639	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000932	0.00625	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000925	0.0062	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000905	0.00607	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000903	0.00606	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000903	0.00606	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000895	0.00601	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000884	0.00593	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000884	0.00593	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000877	0.00588	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00084	0.00563	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000822	0.00551	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000813	0.00546	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000804	0.00539	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000796	0.00534	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000787	0.00528	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000765	0.00513	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000749	0.00502	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000726	0.00487	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00071	0.00476	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000695	0.00466	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00068	0.00456	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000659	0.00442	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000645	0.00433	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000601	0.00403	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000588	0.00395	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000563	0.00378	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000551	0.0037	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000538	0.00361	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000534	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000534	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000527	0.00353	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000522	0.0035	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000522	0.0035	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000512	0.00343	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000501	0.00336	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000496	0.00333	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000489	0.00328	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000486	0.00326	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00048	0.00322	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000478	0.00321	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00047	0.00315	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00041	0.00275	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000402	0.00269	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000389	0.00261	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000381	0.00256	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000339	0.00228	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000334	0.00224	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000332	0.00223	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000327	0.0022	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000302	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000296	0.00198	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000289	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000283	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000233	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000228	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RAF1—dilated cardiomyopathy	0.0002	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000196	0.00132	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000137	0.000922	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000134	0.000902	CbGpPWpGaD
